Variant report
Variant | esv3490111 |
---|---|
Chromosome Location | chr8:63034248-63041446 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs147818323 | chr8:63034252-63034253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566074302 | chr8:63034281-63034282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141353750 | chr8:63034299-63034300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549280680 | chr8:63034302-63034303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72666308 | chr8:63034308-63034309 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs537681009 | chr8:63034328-63034329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142543818 | chr8:63034338-63034339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149021061 | chr8:63034369-63034370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577359989 | chr8:63034401-63034402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs543920306 | chr8:63034428-63034429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150959398 | chr8:63034432-63034433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140655405 | chr8:63034445-63034446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563489931 | chr8:63034466-63034467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114411667 | chr8:63034467-63034468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542918318 | chr8:63034488-63034489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374146760 | chr8:63034489-63034490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561603551 | chr8:63034506-63034507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72666309 | chr8:63034517-63034518 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs75054363 | chr8:63034520-63034521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187151820 | chr8:63034574-63034575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548717655 | chr8:63034578-63034579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs72666310 | chr8:63034596-63034597 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs528372680 | chr8:63034599-63034600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547872218 | chr8:63034618-63034619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs367635764 | chr8:63034653-63034654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551384801 | chr8:63034694-63034695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73268915 | chr8:63034704-63034705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs36207316 | chr8:63034756-63034757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559460034 | chr8:63034767-63034768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530119899 | chr8:63034772-63034773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548847659 | chr8:63034797-63034798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190033311 | chr8:63034879-63034880 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537645873 | chr8:63034884-63034885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75979427 | chr8:63034913-63034914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571115427 | chr8:63034927-63034928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371663009 | chr8:63034983-63034984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10113426 | chr8:63034992-63034993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs369093170 | chr8:63035005-63035006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs58882625 | chr8:63035019-63035020 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs372869393 | chr8:63035026-63035027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565523754 | chr8:63035053-63035054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs138546357 | chr8:63035055-63035056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555300261 | chr8:63035057-63035058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182098591 | chr8:63035075-63035076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536879194 | chr8:63035088-63035089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544135313 | chr8:63035094-63035095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374794739 | chr8:63035108-63035109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559144774 | chr8:63035121-63035122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs187201492 | chr8:63035161-63035162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs190112255 | chr8:63035165-63035166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63032400-63034600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr8:63034000-63038200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr8:63034200-63036200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr8:63034600-63037400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr8:63037200-63039600 | Enhancers | Brain Germinal Matrix | brain |
6 | chr8:63037400-63038000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr8:63038200-63038600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr8:63039200-63039400 | Enhancers | Aorta | Aorta |
9 | chr8:63040000-63041400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:63040600-63041400 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
11 | chr8:63040800-63041400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr8:63040800-63041400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr8:63041000-63041400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |